Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3025% above fair value
$20.17+0.43 (+2.18%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Cryoport net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cryoport's net income for the twelve months ending Jun 30, 2026 was -$37.39M, down 147.3% year over year. For fiscal 2025 it was $78.30M. The highest annual figure on record is $78.30M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.30M | – |
| FY2024 | Dec 31, 2024 | -$114.76M | – |
| FY2023 | Dec 31, 2023 | -$99.59M | – |
| FY2022 | Dec 31, 2022 | -$37.33M | – |
| FY2021 | Dec 31, 2021 | -$275.53M | – |
| FY2020 | Dec 31, 2020 | -$32.69M | – |
| FY2019 | Dec 31, 2019 | -$18.33M | – |
| FY2018 | Dec 31, 2018 | -$9.56M | – |
| FY2016 | Mar 31, 2016 | -$9.82M | – |
| FY2015 | Mar 31, 2015 | -$7.03M | – |
| FY2014 | Mar 31, 2014 | -$19.57M | – |
| FY2013 | Mar 31, 2013 | -$6.38M | – |
| FY2012 | Mar 31, 2012 | -$7.83M | – |
| FY2011 | Mar 31, 2011 | -$6.15M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$8.26M | -107.6% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$10.54M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$11.64M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$6.94M | -962.5% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $108.87M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$11.98M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$18.68M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $805.00K | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$77.99M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$18.90M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$62.39M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$13.27M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$18.36M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$5.57M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$9.44M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$5.32M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$9.18M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$13.40M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$260.09M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$6.53M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$5.39M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$3.53M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$11.53M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$11.42M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$5.80M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$3.94M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$948.00K | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$12.47M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$2.53M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$2.39M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$2.26M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$2.14M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$2.47M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$2.68M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $0 | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$3.00M | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$2.67M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -$6.61M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -$2.79M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | -$1.41M | – |
See a number that looks wrong?